Dongkook Pharmaceutical Launches 'Orasense', Korea's First Flurbiprofen Gargle-Type Stomatitis Treatment

Dongkook Pharmaceutical's product line for stomatitis treatment.
Photo by Dongkook Pharmaceutical

[Asia Economy Reporter Lee Gwan-joo] Dongkook Pharmaceutical announced on the 7th that it has launched 'Orasense Liquid,' the first gargle-type stomatitis treatment in Korea containing flurbiprofen.

Orasense Liquid contains the analgesic and anti-inflammatory ingredient flurbiprofen, which is absorbed at the site of stomatitis to exert its effect. Unlike ointments or liquids, it is a gargle type that can rinse the entire oral cavity, making it suitable for multiple stomatitis lesions appearing at once or large affected areas.

It comes in a convenient stick-type pouch form, allowing easy treatment of stomatitis anytime and anywhere. It is a colorant-free product for safe use and contains a mint flavor to maintain a refreshing sensation after gargling.

A Dongkook Pharmaceutical official said, “Orasense is a product for those who have endured pain without using existing stomatitis treatments, enabling easier treatment through gargling. We plan to increase awareness of Orasense through various marketing activities in the future.”

Dongkook Pharmaceutical has expanded its stomatitis treatment product line by launching Orasense Liquid following the popular stomatitis ointment 'Oramedi Ointment,' the oral stomatitis vitamin 'Orabiten Tablets' that help manage causes, and the liquid-type stomatitis treatment 'Oramechil Liquid.'

This content was produced with the assistance of AI translation services.